Table 3.
Patient covariates and overall and GU complications.
| Covariate | Complications (n=63) (n, row %) | p | GU Complications (n=55) (n, row %) | p |
|---|---|---|---|---|
| Age (categorical) | 0.22 | 0.29 | ||
| <50 years old | 6 (42.9) | 5 (35.7) | ||
| 50–59 years old | 13 (33.3) | 10 (25.6) | ||
| 60–69 years old | 19 (31.2) | 18 (29.5) | ||
| 70–79 years old | 12 (18.8) | 10 (15.6) | ||
| 80+ years old | 13 (24.1) | 12 (22.2) | ||
| Gender | 0.69 | 0.22 | ||
| Male | 50 (27.8) | 46 (25.6) | ||
| Female | 13 (25.0) | 9 (17.3) | ||
| Prior intravesical chemotherapy | 0.13 | 0.32 | ||
| Yes | 17 (21.3) | 16 (20.0) | ||
| No | 46 (30.5) | 39 (25.8) | ||
| Diagnosis of BPH/OAB | 1.00 | 0.97 | ||
| Yes | 15 (27.3) | 13 (23.6) | ||
| No | 48 (27.2) | 42 (23.9) | ||
| Prior pelvic radiation | 0.20 | 0.42 | ||
| Yes | 3 (14.3) | 3 (14.3) | ||
| No | 60 (28.6) | 52 (24.8) | ||
| Charlson comorbidity score | 0.47 | 0.36 | ||
| 0 | 25 (24.5) | 20 (19.6) | ||
| 1–2 | 22 (26.5) | 21 (25.3) | ||
| 3+ | 16 (34.0) | 14 (29.8) | ||
| Year of operation | 0.06 | 0.18 | ||
| 2008 † | 18 (35.2) | 13 (25.5) | ||
| 2009 | 16 (38.1) | 15 (35.7) | ||
| 2010 | 12 (18.8) | 12 (18.8) | ||
| 2011 ‡ | 17 (22.7) | 15 (20.0) | ||
| Site of operation | 0.07 | 0.20 | ||
| Home institution | 58 (29.6) | 30 (25.5) | ||
| Outside institution | 5 (14.3) | 5 (14.3) | ||
| Pathologic stage | <0.01 | 0.02 | ||
| T0 | 3 (8.8) | 3 (8.8) | ||
| Ta/Tis * | 52 (34.4) | 45 (29.8) | ||
| T1 | 6 (23.1) | 5 (19.2) | ||
| T2 | 2 (10.0) | 2 (10.0) |
Abbreviations: GU – genitourinary; BPH – benign prostatic hyperplasia; OAB – overactive bladder
†
Two cases prior to 2008
‡
Three cases from 2012
*
Includes nine patients with CIS